SE311019B - - Google Patents

Info

Publication number
SE311019B
SE311019B SE6834/63A SE683463A SE311019B SE 311019 B SE311019 B SE 311019B SE 6834/63 A SE6834/63 A SE 6834/63A SE 683463 A SE683463 A SE 683463A SE 311019 B SE311019 B SE 311019B
Authority
SE
Sweden
Application number
SE6834/63A
Inventor
P Janssen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE311019B publication Critical patent/SE311019B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Wire Processing (AREA)
  • Hydrogenated Pyridines (AREA)
SE6834/63A 1962-06-22 1963-06-19 SE311019B (US06262066-20010717-C00359.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20462362A 1962-06-22 1962-06-22

Publications (1)

Publication Number Publication Date
SE311019B true SE311019B (US06262066-20010717-C00359.png) 1969-05-27

Family

ID=22758700

Family Applications (1)

Application Number Title Priority Date Filing Date
SE6834/63A SE311019B (US06262066-20010717-C00359.png) 1962-06-22 1963-06-19

Country Status (9)

Country Link
BE (1) BE633914A (US06262066-20010717-C00359.png)
CH (1) CH462835A (US06262066-20010717-C00359.png)
DE (1) DE1470125C3 (US06262066-20010717-C00359.png)
DK (1) DK119880B (US06262066-20010717-C00359.png)
FI (1) FI46967C (US06262066-20010717-C00359.png)
FR (6) FR1573808A (US06262066-20010717-C00359.png)
GB (1) GB1043141A (US06262066-20010717-C00359.png)
NO (1) NO117368B (US06262066-20010717-C00359.png)
SE (1) SE311019B (US06262066-20010717-C00359.png)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080328A (en) * 1971-07-13 1978-03-21 Sumitomo Chemical Company, Limited N-substituted heterocyclic derivatives and preparation thereof
BE792187A (fr) * 1971-12-03 1973-03-30 Sumitomo Chemical Co Nouveaux derives d'alkylamines
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
NZ181256A (en) * 1975-07-21 1978-04-28 Janssen Pharmaceutica Nv 1-(w-benzazol-11-ylalkyl)-piperidine derivatives and pharmaceutical compositions containing certain of these derivatives
DK139684A (da) * 1983-04-11 1984-10-12 Janssen Pharmaceutica Nv N-aryl-alpha-amino-carboxamider
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5574041A (en) * 1990-03-16 1996-11-12 Beth Israel Hospital Association Use of spiperone derivatives as immunosuppressant agents
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
DE19610397A1 (de) * 1996-03-16 1997-09-18 Krewel Meuselbach Gmbh Gewinnung von Fluspirilen-Suspensionen
US6277991B1 (en) 1998-05-18 2001-08-21 Novo Nordisk A/S 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
EP1080091A1 (en) * 1998-05-18 2001-03-07 Novo Nordisk A/S Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
ES2237047T3 (es) * 1998-10-23 2005-07-16 Pfizer Inc. Compuestos de 1,3,8-triazaespiro(4,5)decanona como agonistas del receptor orl1.
US7459461B2 (en) 2001-10-19 2008-12-02 Ortho-Mcneil Pharmaceutical, Inc. Phosphonic acid compounds as inhibitors of serine proteases
DE102005038141A1 (de) * 2005-08-12 2007-02-15 Grünenthal GmbH Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate
KR101601383B1 (ko) * 2010-06-18 2016-03-08 알토스 세라퓨틱스, 엘엘씨 D2 길항제, 합성 방법 및 사용 방법
IT201800007580A1 (it) * 2018-07-27 2020-01-27 Maria Cecilia Hospital Spa Composti 1,3,8-triazaspiro e loro uso come medicamenti

Also Published As

Publication number Publication date
DE1470125B2 (US06262066-20010717-C00359.png) 1979-10-31
CH462835A (de) 1968-09-30
NO117368B (US06262066-20010717-C00359.png) 1969-08-04
FR3059M (fr) 1965-01-11
FR2986M (fr) 1964-12-07
FI46967B (US06262066-20010717-C00359.png) 1973-05-02
DE1470125C3 (de) 1980-07-10
FR2988M (fr) 1964-12-07
FI46967C (fi) 1973-08-10
DK119880B (da) 1971-03-08
FR3043M (fr) 1965-01-04
DE1470125A1 (de) 1969-05-08
FR2987M (fr) 1964-12-07
GB1043141A (en) 1966-09-21
BE633914A (US06262066-20010717-C00359.png)
FR1573808A (US06262066-20010717-C00359.png) 1969-07-11

Similar Documents

Publication Publication Date Title
FI46967B (US06262066-20010717-C00359.png)
BE616548R (US06262066-20010717-C00359.png)
BE380301A (US06262066-20010717-C00359.png)
BE612311A (US06262066-20010717-C00359.png)
BE614159A (US06262066-20010717-C00359.png)
BE613862A (US06262066-20010717-C00359.png)
BE613529A (US06262066-20010717-C00359.png)
BE613335A (US06262066-20010717-C00359.png)
BE613319A (US06262066-20010717-C00359.png)
BE615849A (US06262066-20010717-C00359.png)
BE613190A (US06262066-20010717-C00359.png)
BE613108A (US06262066-20010717-C00359.png)
BE612926A (US06262066-20010717-C00359.png)
BE612847A (US06262066-20010717-C00359.png)
BE612464A (US06262066-20010717-C00359.png)
BE612190A (US06262066-20010717-C00359.png)
BE609543A (US06262066-20010717-C00359.png)
BE635354A (US06262066-20010717-C00359.png)
BE633835A (US06262066-20010717-C00359.png)
BE632697A (US06262066-20010717-C00359.png)
BE631751A (US06262066-20010717-C00359.png)
BE631415A (US06262066-20010717-C00359.png)
BE630994A (US06262066-20010717-C00359.png)
BE608197A (US06262066-20010717-C00359.png)
BE604335A (US06262066-20010717-C00359.png)